Skip to main content

Aggie Czapla, MD


Board Certifications

Cytopathology, Anatomic and Clinical Pathology


Cytopathology, Breast Pathology




ProPath, a Sonic Healthcare anatomic pathology practice, is pleased to include Aggie Czapla, M.D., as a part of its dynamic medical staff. Dr. Czapla is a double board-certified pathologist who brings professional medical and teaching experience to her position.

Dr. Czapla graduated with a Bachelor of Science in microbiology from the University of Miami in Coral Gables, Florida. She then earned her medical degree from the American University of the Caribbean in Cupecoy, St. Maarten. She served an anatomic and clinical pathology residency at Allegheny Health Network in Pittsburgh, Pennsylvania, where she served as chief resident. Dr. Czapla completed two fellowships. The first was a cytopathology fellowship at Loyola University Medical Center in Maywood, Illinois. The second was a fellowship in breast pathology at the University of Texas Southwestern Medical Center in Dallas.

Dr. Czapla has professional medical, leadership and teaching experience. While at UT Southwestern, she presented to the multidisciplinary breast tumor board and worked on radiology pathology correlation. Dr. Czapla has been a member of ProPath’s pathology team since 2017. Since then, she has also been appointed as the PPS medical director at Texas Health Harris Methodist Hospital Southwest Fort Worth. She also sits on a number of professional committees. She sits on the membership and progressive evaluation of competency question committees for the American Society of Cytopathology. Previously, she was a member of the cancer committee and pathology residency candidate selection committee at AlleghenyHealth Network.

Dr. Czapla has peer-reviewed manuscripts in medical journals, including Diagnostic Cytopathology and BMJ Case Reports. She has also presented multiple abstracts at professional conferences, including meetings of the United States and Canadian Academy of Pathology and the American Society of Clinical Pathology.

Dr. Czapla belongs to several professional organizations. These include: the American Society of Cytopathology, College of American Pathologists, Texas Society of Pathologists, and the United States and Canadian Academy of Pathology.

Dr. Czapla holds full medical licensure and is board-certified in cytopathology and anatomic and clinical pathology by the American Board of Pathology.



University of Miami (BS)
Coral Gables, FL

American University of the Caribbean (MD)
Cupecoy, St. Maarten


Postgraduate Training

Breast Pathology Fellowship
University of Texas Southwestern Medical Center
Dallas, TX

Cytopathology Fellowship
Loyola University Medical Center
Maywood, IL

Anatomic and Clinical Pathology Residency
Allegheny Health Network
Pittsburgh, PA


Professional Memberships

American Society of Cytopathology
College of American Pathologists
Texas Society of Pathologists
United States & Canadian Academy of Pathology


Peer-Reviewed Articles

  1. Czapla A, Omman RA, Nam W, Mehrotra S, Pambuccian SE. “Medusa-head” cells, “starfish” cells, and interconnecting long cytoplasmic processes as diagnostic cytologic clues for follicular dendritic cell sarcoma in fine needle aspiration samples. Diagn Cytopathol. 2017;45(4):322-326.

  2. Gurram KC, Czapla A, Thakkar S. Acute pancreatitis: pancreas divisum with ventral duct intraductal papillary mucinous neoplasms. BMJ Case Rep. 2014 Oct 7. doi:10.1136/bcr-2014-205322.


  1. Czapla A, Hwang H. One H&E stain is sufficient for evaluation of sentinel lymph nodes in breast cancer. USCAP Meeting, San Antonio, TX, 2017.

  2. Czapla A, Silverman J, Krishnamurti U. Evaluation of CIN1 loop electrosurgical excision procedure (LEEP) specimens following an initial colposcopic biopsy diagnosis of CIN2: retrospective p16 immunostaining on the initial colposcopic biopsies [abstract 1123]. USCAP Meeting, Boston, MA, 2015. Mod Pathol. 2015;28(suppl 2s):281A.

  3. Czapla A, Silverman J, Krishnamurti U. Discordance between HER2 copies/cell and HER2/CEP17 ratio by fluorescence in situ hybridization (FISH) in invasive breast carcinoma [abstract 163]. USCAP Meeting, San Diego, CA, 2014 Mod Pathol. 2014;27(suppl 2s):43A

  4. Czapla A, Silverman J. What is the utility of cytologic and surgical pathologic examination in the workup of endobronchial hamartomas? American Society of Clinical Pathology, Tampa, FL, 2014.